Pharma & Healthcare Mutual Funds in India specialize in investing in pharmaceutical companies, biotechnology firms, and related healthcare industries.
Long Horizon
21 Funds
₹30,378 Cr Total AUM
Sort By
Fund name | Fund size | Expense Ratio | 3Y Returns |
---|---|---|---|
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth Sector - Healthcare Very High Risk | ₹5,044 Cr | 1.09% | 27.0% |
SBI Healthcare Opportunities Fund Direct Growth Sector - Healthcare Very High Risk | ₹3,459 Cr | 0.89% | 26.5% |
DSP Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹3,248 Cr | 0.59% | 24.7% |
Tata India Pharma & Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹1,213 Cr | 0.69% | 24.6% |
ITI Pharma and Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹217 Cr | 0.47% | 23.4% |
UTI Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹1,203 Cr | 1.25% | 23.4% |
Nippon India Pharma Fund Direct Growth Sector - Healthcare Very High Risk | ₹8,638 Cr | 0.91% | 22.0% |
Mirae Asset Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹2,742 Cr | 0.47% | 21.6% |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹854 Cr | 0.92% | 21.3% |
LIC MF Healthcare Fund Direct Growth Sector - Healthcare Very High Risk | ₹84 Cr | 1.21% | 20.2% |
Identify red flags in your mutual funds and how to fix them
By Market Cap
By Diversification
By Sectors & Themes
By Solutions
Invest in mid-sized companies in their growth phase
Invest in the largest 250 companies in India
Invest in the largest 100 companies in India
Invest in small-sized companies in their growth phase
Tracks a market index
Hybrid funds are a combination of equity and debt investments. The blend of these asset classes varies based on the fund's investment goals.
Debt Mutual Funds invest in fixed-income securities such as government bonds, corporate bonds, treasury bills, and other money market instruments.